Compare AngloGold Ashanti Limited (AU) vs Smith & Nephew plc (SNN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AngloGold Ashanti Limited vs Smith & Nephew plc — how do they compare? AngloGold Ashanti Limited trades at $100.32 (market cap $49.28B), while Smith & Nephew plc trades at $30.05 (market cap $12.54B). The key difference: AngloGold Ashanti Limited is far larger — about 3.9× Smith & Nephew plc's market cap, and AngloGold Ashanti Limited pays the higher dividend (4.64%). Which is the better fit depends on your goals.
| AU | SNN | |
|---|---|---|
Market Cap | $49.28B | $12.54B |
Sector | Basic Materials | Health |
52-Week High | $128.26 | $38.70 |
52-Week Low | $52.15 | $28.73 |
Enterprise Value | $48.29B | $15.57B |
Dividend Yield | 4.64% | 2.65% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About AngloGold Ashanti Limited
Anglogold Ashanti Ltd is one of the largest gold miners. The company also produces silver and sulphuric acid as by-products. Its operating divisions are Africa, Australia, and the Americas. The firm generates a majority of its revenue from Africa which includes Ghana, Guinea, Mali, the Democratic Republic of the Congo, and Tanzania.
Read more on AU →About Smith & Nephew plc
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →
